![Funds Advised by Motion Equity Partners to acquire Laboratoire Equilibre Attitude from LFPI and co-investors - Motion Equity Partners Funds Advised by Motion Equity Partners to acquire Laboratoire Equilibre Attitude from LFPI and co-investors - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2018/12/EA-Pharma-brands-vf.png)
Funds Advised by Motion Equity Partners to acquire Laboratoire Equilibre Attitude from LFPI and co-investors - Motion Equity Partners
EISAI CO., LTD. AND AJINOMOTO CO., INC. ANNOUNCE ESTABLISHMENT OF GASTROINTESTINAL SPECIALTY PHARMA EA PHARMA CO., LTD. THROUGH
![Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease - Catalys Pacific Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease - Catalys Pacific](https://catalyspacific.com/wp-content/uploads/2022/03/news-default-01.jpeg)
Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease - Catalys Pacific
![Cooper Consumer Health has sold Stardea to EA Pharma | Deals | Oaklins Italy: Mid-market M&A and financial advice globally Cooper Consumer Health has sold Stardea to EA Pharma | Deals | Oaklins Italy: Mid-market M&A and financial advice globally](https://www.oaklins.com/api/deal-party-images/108297/deal-parties.png)
Cooper Consumer Health has sold Stardea to EA Pharma | Deals | Oaklins Italy: Mid-market M&A and financial advice globally
![Cooper Consumer Health has sold Stardea to EA Pharma | Deals | Oaklins Italy: Mid-market M&A and financial advice globally Cooper Consumer Health has sold Stardea to EA Pharma | Deals | Oaklins Italy: Mid-market M&A and financial advice globally](https://www.oaklins.com/api/deal-hero-image/108297/deal-hero-image.jpg)